We are live on ! Find out more
OAM

Oppenheimer Asset Management Portfolio holdings

AUM $9.63B
1-Year Est. Return 30.32%
This Fund
S&P 500
This Quarter Est. Return
+7.75%
1 Year Est. Return
+30.32%
3 Year Est. Return
+85%
5 Year Est. Return
+99.62%
10 Year Est. Return
+601.29%
AUM
$7.54B
AUM Growth
+$509M
Cap. Flow
+$81.8M
Cap. Flow %
1.08%
Top 10 Hldgs %
15.04%
Holding
1,277
New
87
Increased
539
Reduced
599
Closed
49

Sector Composition

Rank Sector Weight
1 Technology 21.29%
2 Healthcare 13.85%
3 Financials 13.17%
4 Consumer Discretionary 10.27%
5 Industrials 8.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EHC icon
526
Encompass Health
EHC
$12.4B
$2.2M 0.03%
42,394
+10,137
+31% +$523K
HQY icon
527
HealthEquity
HQY
$8.75B
$2.19M 0.03%
49,602
+8,922
+22% +$520K
MSI icon
528
Motorola Solutions
MSI
$77.4B
$2.16M 0.03%
7,951
-847
-10% -$213K
MANH icon
529
Manhattan Associates
MANH
$11.4B
$2.16M 0.03%
13,867
+1,186
+9% +$193K
CTVA icon
530
Corteva
CTVA
$51.3B
$2.15M 0.03%
45,563
+800
+2% +$36.4K
MTCH icon
531
Match Group
MTCH
$8.55B
$2.12M 0.03%
16,033
+4,453
+38% +$645K
MNTV
532
DELISTED
Momentive Global Inc. Common Stock
MNTV
$2.12M 0.03%
100,282
-4,962
-5% -$109K
MD icon
533
Pediatrix Medical
MD
$2.2B
$2.11M 0.03%
77,602
-8,181
-10% -$219K
BEPC icon
534
Brookfield Renewable
BEPC
$6.26B
$2.11M 0.03%
57,276
-232
-0.4% -$8.85K
NDSN icon
535
Nordson
NDSN
$17.3B
$2.1M 0.03%
8,250
-225
-3% -$57.6K
RGA icon
536
Reinsurance Group of America
RGA
$16.1B
$2.1M 0.03%
19,162
+147
+0.8% +$16.3K
CNS icon
537
Cohen & Steers
CNS
$4.3B
$2.1M 0.03%
22,645
+1,602
+8% +$148K
AYI icon
538
Acuity Brands
AYI
$10.8B
$2.07M 0.03%
9,768
+1,506
+18% +$311K
BR icon
539
Broadridge
BR
$19B
$2.07M 0.03%
11,309
+899
+9% +$158K
GPN icon
540
Global Payments
GPN
$22.8B
$2.07M 0.03%
15,298
-21,511
-58% -$2.97M
LUV icon
541
Southwest Airlines
LUV
$23B
$2.06M 0.03%
48,097
+5,813
+14% +$273K
SYNH
542
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$2.05M 0.03%
20,008
-4,770
-19% -$458K
KNSL icon
543
Kinsale Capital Group
KNSL
$8.51B
$2.05M 0.03%
8,604
+1,646
+24% +$324K
YUM icon
544
Yum! Brands
YUM
$41.1B
$2.04M 0.03%
14,657
+297
+2% +$38K
NTRA icon
545
Natera
NTRA
$46.4B
$2.03M 0.03%
21,734
-3,153
-13% -$327K
HMC icon
546
Honda
HMC
$41.3B
$2.03M 0.03%
71,242
-7,589
-10% -$221K
WING icon
547
Wingstop
WING
$3.18B
$2.02M 0.03%
11,707
+1,355
+13% +$227K
LYG icon
548
Lloyds Banking Group
LYG
$91.3B
$2.02M 0.03%
791,598
-40,425
-5% -$103K
MRTN icon
549
Marten Transport
MRTN
$1.22B
$2.01M 0.03%
117,328
-8,873
-7% -$147K
SBAC icon
550
SBA Communications
SBAC
$19.5B
$2.01M 0.03%
5,165
-808
-14% -$284K

Similar funds

Oppenheimer Asset Management's Q4 2021 Portfolio in Review

As of Q4 2021, Oppenheimer Asset Management held 1,277 positions worth $7.54B, up 7.2% from $7.03B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Oppenheimer Asset Management's Q4 2021 filing shows 87 new, 539 increased, 599 reduced and 49 closed positions. Its largest new stake was Vanguard FTSE All-World ex-US ETF: 241,081 shares worth $14.8M. The largest sale was Autodesk, an estimated $9.15M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

  • Oppenheimer Asset Management's largest Q4 2021 buy was Vanguard FTSE All-World ex-US ETF: 241,081 shares worth $14.8M.
  • Oppenheimer Asset Management added most to iShares Currency Hedged MSCI EAFE ETF in Q4 2021, an estimated $18.6M increase.
  • Oppenheimer Asset Management's biggest Q4 2021 reduction was Autodesk, cutting an estimated $9.15M.
  • Oppenheimer Asset Management fully exited iShares MSCI EAFE Growth ETF in Q4 2021, selling an estimated $7.45M.
  • Oppenheimer Asset Management's ten largest holdings make up 15% of its $7.54B portfolio in Q4 2021.
  • Oppenheimer Asset Management opened 87 new positions and closed 49 in Q4 2021.
  • Oppenheimer Asset Management's portfolio value rose 7.2% quarter-over-quarter to $7.54B.

Based on Oppenheimer Asset Management's 13F filing for Q4 2021, filed 2 Feb 2022.